ADAMTS proteoglycanases in the physiological and pathological central nervous system

72Citations
Citations of this article
99Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

ADAMTS-1, -4, -5 and -9 belong to 'a disintegrin and metalloproteinase with thrombospondin motifs (ADAMTS)' family and more precisely to the proteoglycanases subgroup based on their common ability to degrade chondroitin sulfate proteoglycans. They have been extensively investigated for their involvement in inflammation-induced osteoarthritis, and a growing body of evidence indicates that they may be of key importance in the physiological and pathological central nervous system (CNS). In this review, we discuss the deregulated expression of ADAMTS proteoglycanases during acute CNS injuries, such as stroke and spinal cord injury. Then, we provide new insights on ADAMTS proteoglycanases mediating synaptic plasticity, neurorepair, angiogenesis and inflammation mechanisms. Altogether, this review allows us to propose that ADAMTS proteoglycanases may be original therapeutic targets for CNS injuries. © 2013 Lemarchant et al.; licensee BioMed Central Ltd.

Cite

CITATION STYLE

APA

Lemarchant, S., Pruvost, M., Montaner, J., Emery, E., Vivien, D., Kanninen, K., & Koistinaho, J. (2013, October 31). ADAMTS proteoglycanases in the physiological and pathological central nervous system. Journal of Neuroinflammation. BioMed Central. https://doi.org/10.1186/1742-2094-10-133

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free